scholarly journals Research-Tested Mobile Apps for Breast Cancer Care: Systematic Review (Preprint)

2018 ◽  
Author(s):  
Chiara Jongerius ◽  
Selena Russo ◽  
Ketti Mazzocco ◽  
Gabriella Pravettoni
Keyword(s):  
Breast Cancer ◽  
Early Detection ◽  
Cancer Prevention ◽  
Cancer Care ◽  
Care Management ◽  
Breast Cancer Prevention ◽  
Breast Cancer Care ◽  
Prevention And Early Detection ◽  
The Impact ◽  
Mhealth Apps

BACKGROUND The use of mobile health (mHealth) apps in clinical settings is increasing widely. mHealth has been used to promote prevention, improve early detection, manage care, and support survivors and chronic patients. However, data on the efficacy and utility of mHealth apps are limited. OBJECTIVE The main objective of this review was to provide an overview of the available research-tested interventions using mHealth apps and their impact on breast cancer care. METHODS A systematic search of Medline, PsycINFO, Embase, and Scopus was performed to identify relevant studies. From the selected studies, the following information was extracted: authors, publication date, study objectives, study population, study design, interventions’ features, outcome measures, and results. RESULTS We identified 29 empirical studies that described a health care intervention using an mHealth app in breast cancer care. Of these, 7 studies were about the use of an mHealth application in an intervention for breast cancer prevention and early detection, 12 targeted care management, and 10 focused on breast cancer survivors. CONCLUSIONS Our results indicate consistent and promising findings of interventions using mHealth apps that target care management in breast cancer. Among the categories of mHealth apps focusing on survivorship, mHealth-based interventions showed a positive effect by promoting weight loss, improving the quality of life, and decreasing stress. There is conflicting and less conclusive data on the effect of mHealth apps on psychological dimensions. We advocate further investigation to confirm and strengthen these findings. No consistent evidence for the impact of interventions using mHealth apps in breast cancer prevention and early detection was identified due to the limited number of studies identified by our search. Future research should continue to explore the impact of mHealth apps on breast cancer care to build on these initial recommendations.

The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs

2006 ◽  
Vol 101 (1) ◽  
pp. 95-104 ◽  
Author(s):  
Peter A. Fasching ◽  
Gunter von Minckwitz ◽  
Thorsten Fischer ◽  
Manfred Kaufmann ◽  
Beate Schultz-Zehden ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Socioeconomic Status ◽  
Cancer Prevention ◽  
Breast Cancer Prevention ◽  
Cancer Awareness ◽  
Breast Cancer Awareness ◽  
The Impact ◽  
To Receive

scholarly journals Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities

2020 ◽  
Vol 16 (11) ◽  
pp. e1304-e1314 ◽  
Author(s):  
Francesca Poggio ◽  
Marco Tagliamento ◽  
Massimo Di Maio ◽  
Valentino Martelli ◽  
Andrea De Maria ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Care ◽  
Weekly Paclitaxel ◽  
Breast Cancer Care ◽  
Related Research ◽  
Research Activities ◽  
Monitoring Therapy ◽  
Medical Oncologists ◽  
Metastatic Setting ◽  
The Impact

PURPOSE: To investigate the impact of the COVID-19 outbreak on the attitudes and practice of Italian oncologists toward breast cancer care and related research activities. METHODS: A 29-question anonymous online survey was sent by e-mail to members of the Italian Association of Medical Oncology and the Italian Breast Cancer Study Group on April 3, 2020. Only medical oncologists (both those in training and specialists) were invited to complete the questionnaire. RESULTS: Out of 165 responding oncologists, 121 (73.3.%) worked in breast units. In the (neo)adjuvant setting, compared with before the emergency, fewer oncologists adopted weekly paclitaxel (68.5% v 93.9%) and a dose-dense schedule for anthracycline-based chemotherapy (43% v 58.8%) during the COVID-19 outbreak. In the metastatic setting, compared with before the emergency, fewer oncologists adopted first-line weekly paclitaxel for HER2-positive disease (41.8% v 53.9%) or CDK4/6 inhibitors for luminal tumors with less-aggressive characteristics (55.8% v 80.0%) during the COVID-19 outbreak. A significant change was also observed in delaying the timing for monitoring therapy with CDK4/6 inhibitors, assessing treatment response with imaging tests, and flushing central venous devices. Clinical research and scientific activities were reduced in 80.3% and 80.1% of respondents previously implicated in these activities, respectively. CONCLUSION: Medical oncologists face many challenges in providing cancer care during the COVID-19 outbreak. Although most of the changes in their attitudes and practice were reasonable responses to the current health care emergency without expected major negative impact on patient outcomes, some potentially alarming signals of undertreatment were observed.

The Impact of Patient Shifts between Hospitals on Breast Cancer Care: A population based study in The Netherlands

2018 ◽  
Vol 92 ◽  
pp. S49
Author(s):  
E. Heeg ◽  
K. Schreuder ◽  
P.E.R. Spronk ◽  
J.C. Oosterwijk ◽  
S. Siesling ◽  
...  
Keyword(s):  
Breast Cancer ◽  
The Netherlands ◽  
Cancer Care ◽  
Population Based ◽  
Breast Cancer Care ◽  
Population Based Study ◽  
The Impact

scholarly journals Modifiable Lifestyle Factors: Opportunities for (Hereditary) Breast Cancer Prevention - a Narrative Review

Breast Care ◽  
2018 ◽  
Vol 13 (2) ◽  
pp. 108-113 ◽  
Author(s):  
Jacqueline Lammert ◽  
Sabine Grill ◽  
Marion Kiechle
Keyword(s):  
Breast Cancer ◽  
Risk Factors ◽  
Breast Cancer Risk ◽  
Cancer Risk ◽  
Cancer Prevention ◽  
Healthy Lifestyle ◽  
Absolute Risk ◽  
Lifestyle Factors ◽  
Breast Cancer Prevention ◽  
The Impact

Increasing rates of obesity, lack of physical activity, sedentary behavior, and frequent alcohol consumption are major lifestyle-related risk factors for breast cancer. In fact, it has been estimated that about one-third of breast cancer cases are attributable to factors women can change. Most research has focused on examining the impact of one single exposure on breast cancer risk while adjusting for other risk modifiers. Capitalizing on big data, major efforts have been made to evaluate the combined impact of well-established lifestyle factors on overall breast cancer risk. At the individual level, data indicate that even simple behavior modifications could have a considerable impact on breast cancer prevention. Moreover, there is emerging new evidence that adopting a healthy lifestyle may be particularly relevant for women with hereditary susceptibility to breast cancer. On the absolute risk scale, studies suggest that the presence of certain risk factors, such as excessive body weight, had a substantially higher impact on breast cancer risk if women had a hereditary predisposition to cancer. The existing body of knowledge gives the medical professionals guidance as to which factors to focus on when counseling patients. However, well-designed randomized controlled trials utilizing objective methods are crucial to providing concrete recommendations.

scholarly journals Breast Cancer Prevention-Is there a Future for Sulforaphane and Its Analogs?

Nutrients ◽  
2020 ◽  
Vol 12 (6) ◽  
pp. 1559
Author(s):  
Dominika Kuran ◽  
Anna Pogorzelska ◽  
Katarzyna Wiktorska
Keyword(s):  
Breast Cancer ◽  
Cancer Prevention ◽  
Initial Study ◽  
Dietary Factors ◽  
Breast Cancer Prevention ◽  
In Vivo Studies ◽  
Cancer Etiology ◽  
The Impact

Breast cancer is the most prevalent type of cancer among women worldwide. There are several recommended methods of breast cancer prevention, including chemoprevention. There are several approved drugs used to prevent breast cancer occurrence or recurrence and metastasizing. There are also a number of new substances undergoing clinical trials and at the stage of initial study. Studies suggest that dietary factors play a crucial role in breast cancer etiology. Epidemiological studies indicate that in particular vegetables from the Brassicaceae family are a rich source of chemopreventive substances, with sulforaphane (SFN) being one of the most widely studied and characterized. This review discusses potential applicability of SFN in breast cancer chemoprevention. A comprehensive review of the literature on the impact of SFN on molecular signalling pathways in breast cancer and breast untransformed cells is presented. The presented results of in vitro and in vivo studies show that this molecule has a potential to act as a preventive molecule either to prevent disease development or recurrence and metastasizing, and as a compound protecting normal cells against the toxic effects of cytostatics. Finally, the still scanty attempts to develop an improved analog are also presented and discussed.

Sign in / Sign up

Export Citation Format

Share Document